Neurology
Commentary
Discontinuing Disease-Modifying Therapies in Nonactive Secondary Progressive MS:Review of the Evidence
Background: There are currently no disease-modifying therapies (DMTs) on the market approved for nonactive secondary...
Latest News
AI model interprets EEGs with near-perfect accuracy
The technology distinguishes between abnormal and normal EEG recordings and classifies irregular recordings into specific categories crucial for...
News
New data on traumatic brain injury show it’s chronic, evolving
“Our results dispute the notion that TBI is a discrete, isolated medical event with a finite, static functional outcome following a relatively...
News
FDA clears new biomarker assays for early Alzheimer’s detection
Currently, the only FDA-cleared methods to confirm amyloid pathology are CSF tests and PET scans.
Latest News
No link between heartburn meds and dementia
A study of older adults found no significant association between proton pump inhibitors or histamine-2 receptor antagonist use and dementia or...
Latest News
Women with atrial fibrillation more likely to develop dementia
Authors say cognitive screening should be part of yearly visits for men and women with AF; early rhythm control and anticoagulation are also key...
Conference Coverage
Migraine device expands treatment possibilities
New studies of remote electrical neuromodulation show efficacy in adolescents and safety during pregnancy.
News
Regular napping linked to greater brain volume
“Our results suggest that napping may improve brain health.”
Latest News
No link between PPIs and dementia in new study
PPI use was not linked to changes in overall cognitive test scores over time.
News
Altered gut bacteria a biomarker of preclinical Alzheimer’s?
It’s not known whether the gut is influencing the brain, or the brain is influencing the gut, “but this association is valuable to know in either...